Clover Health Investments Corp (BSP:CLOV34)
R$ 21.55 (0%) Market Cap: 11.35 Bil Enterprise Value: 10.11 Bil PE Ratio: 0 PB Ratio: 6.88 GF Score: 55/100

Q2 2026 Clover Health Investments Corp Earnings Call Transcript

Aug 5, 2026 / 09:00 PM GMT
Release Date Price: R$21.55 (+0.61%)

Key Points

Positve
  • Clover Health Investments Corp (CLOV) reported strong financial results for Q2 2026, with revenue and earnings exceeding expectations.
  • The company's Medicare Advantage plans continue to show robust membership growth, driving higher premium revenue.
  • Clover Health Investments Corp (CLOV) successfully reduced its medical cost ratio, indicating improved underwriting and cost management.
  • The company's Clover Assistant platform is gaining traction, leading to better patient outcomes and operational efficiencies.
  • Clover Health Investments Corp (CLOV) raised its full-year 2026 guidance, reflecting confidence in sustained growth and profitability.
Negative
  • Clover Health Investments Corp (CLOV) faces intense competition in the Medicare Advantage market, which could pressure future growth.
  • The company's reliance on a limited number of markets exposes it to regional regulatory and reimbursement changes.
  • Clover Health Investments Corp (CLOV) continues to experience high administrative costs, which may limit margin expansion.
  • The company's dependence on its proprietary technology platform poses risks if system disruptions or data breaches occur.
  • Clover Health Investments Corp (CLOV) remains subject to ongoing regulatory scrutiny, which could lead to compliance costs or penalties.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CLOV.OQ - Clover Health Investments, Corp.
Q2 2026 Clover Health Investments Corp Earnings Call
Aug 05, 2026 / 09:00PM GMT

--------------------------------------------------------------------------
Definitions
--------------------------------------------------------------------------
PRELIMINARY TRANSCRIPT: "Preliminary Transcript" indicates that the
Transcript has been published in near real-time by an experienced
professional transcriber. While the Preliminary Transcript is highly
accurate, it has not been edited to ensure the entire transcription
represents a verbatim report of the call.

EDITED TRANSCRIPT: "Edited Transcript" indicates that a team of professional
editors have listened to the event a second time to confirm that the
content of the call has been transcribed accurately and in full.

--------------------------------------------------------------------------
Disclaimer
--------------------------------------------------------------------------
Refinitiv reserves the right to make
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot